Akèy › Sipwa › Maryland › Baltimore
Etid klinik pou Sipwa nan Baltimore, MD
17 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Ap rekriteFaz 3
- Barry J. Reiner, MD LLC, Baltimore
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
- Ascension Saint Agnes Heart Care, Baltimore
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Ap rekriteFaz 3
- Johns Hopkins Children's Center, Baltimore
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Ascension Saint Agnes Heart Care, Baltimore
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- MedStar Good Samaritan Hospital, Baltimore
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
Ap rekriteFaz 1Volontè an sante akeyi
- Research Site, Brooklyn · 4 mi lwen
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- Baltimore VA Medical Center, Baltimore
- Johns Hopkins University School of Nursing, Baltimore
A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
Ap rekriteFaz 1
- PAREXEL Intl - EPCU-Baltimore, Baltimore
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
Ap rekriteFaz 2
- Johns Hopkins University, Baltimore
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Annapolis · 22 mi lwen
Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
Ap rekrite
- Johns Hopkins School of Nursing, Baltimore
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
Ap rekriteFaz 1/2Volontè an sante akeyi
- Parexel International-EPCU Baltimore, Baltimore
Night Owl Metabolism
Ap rekriteVolontè an sante akeyi
- Johns Hopkins School of Medicine, Baltimore
Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity
Ap rekrite
- Johns Hopkins University, Baltimore
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Ap rekriteFaz 2
- Johns Hopkins University, Baltimore
Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
Ap rekrite
- Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
Ap rekriteFaz 1Volontè an sante akeyi
- Pharmaron CPC, Inc, Baltimore
Etid Sipwa nan lòt vil
- San Antonio, TX34 etid
- Houston, TX33 etid
- Chicago, IL28 etid
- Orlando, FL27 etid
- Las Vegas, NV23 etid
- Miami, FL23 etid
- Atlanta, GA20 etid
- Dallas, TX20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Kansè (tout kalite)37 etid
- Kansè kolorektal31 etid
- Kansè pankreyas31 etid
- Kansè Metastatik28 etid
- Obèsite25 etid
- Ensifizyans kadyak24 etid
- Kansè vejik24 etid
- Akidan serebavaskilè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.